The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The approval was based on data from 2 randomized, double-blind, placebo-controlled trials, ARCADIA 1 and ARCADIA 2.

Switzerland’s Galderma has won US Food and Drug Administration (FDA) approval for the use of Nemluvio (nemolizumab) for ...

Finding the perfect gift can be a challenge, especially as time runs out. That’s why we’ve rounded up thoughtful and unique ...

Kyle has had moderate to severe eczema across most of his body since he was an infant. Throughout his life, he’s faced a mix ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.

Featuring Profiles of Ethraa Medical, Al Amin Medical Instruments, Alma Lasers, DermLiTe, Cynosure, Candela, Abvie, Henry ...

The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of ...